Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
Stopped The trial ended early due to GI intolerability and treatment-emergent resistance.
Conditions
- Infection, Human Immunodeficiency Virus
Interventions
- DRUG: BMS-955176
- DRUG: EFV
- DRUG: TDF/FTC
Sponsor
ViiV Healthcare
Collaborators